Increased recipient body mass index is associated with acute rejection and other adverse outcomes after kidney transplantation

Transplantation

Volumn 97, Issue 1, 2014, Pages 64-70

  Curran, Simon P ^a   Famure, Olusegun ^a   Li, Yanhong ^a   Kim, S Joseph ^a,b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Body mass index; Kidney transplantation; Outcomes

Indexed keywords

EID: 84893021204     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182a688a4     Document Type: Article

References (36)

1. Collins AJ, Foley RN, Chavers B, et al. United States Renal Data System 2011 annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 2012; 59: A7.
2. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
3. Jofre R, Lopez-Gomez JM, Moreno F, et al. Changes in quality of life after renal transplantation. Am J Kidney Dis 1998; 32: 93.
4. Glanton CW, Kao TC, Cruess D, et al. Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index. Kidney Int 2003; 63: 647.
5. Johnson DW, Herzig K, Purdie D, et al. A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patients. Transplantation 2000; 69: 794.
6. Khauli RB, Steinmuller DR, Novick AC, et al. A critical look at survival of diabetics with end-stage renal disease. Transplantation versus dialysis therapy. Transplantation 1986; 41: 598.
7. Pelletier SJ, Maraschio MA, Schaubel DE, et al. Survival benefit of kidney and liver transplantation for obese patients on the waiting list. Clin Transpl 2003: 77.
8. Pondrom S. The AJT report: news and issues that affect organ and tissue transplantation. Am J Transplant 2012; 12: 1663.
9. Holley JL, Shapiro R, Lopatin WB, et al. Obesity as a risk factor following cadaveric renal transplantation. Transplantation 1990; 49: 387.
10. Johnson DW, Isbel NM, Brown AM, et al. The effect of obesity on renal transplant outcomes. Transplantation 2002; 74: 675.
11. Kuo JH, Wong MS, Perez RV, et al. Renal transplant wound complications in the modern era of obesity. J Surg Res 2011; 173: 216.
12. Lynch RJ, Ranney DN, Shijie C, et al. Obesity, surgical site infection, and outcome following renal transplantation. Ann Surg 2009; 250: 1014.
13. Olarte IG, Hawasli A. Kidney transplant complications and obesity. Am J Surg 2009; 197: 424.
14. Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol 2006; 17: 1453.
15. Friedman AN, Miskulin DC, Rosenberg IH, et al. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis 2003; 41: 480.
16. Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002; 73: 70.
17. Howard RJ, Thai VB, Patton PR, et al. Obesity does not portend a bad outcome for kidney transplant recipients. Transplantation 2002; 73: 53.
18. Modlin CS, Flechner SM, Goormastic M, et al. Should obese patients lose weight before receiving a kidney transplant? Transplantation 1997; 64: 599.
19. Chow KM, Szeto CC, Leung CB, et al. Body mass index as a predictive factor for long-term renal transplant outcomes in Asians. Clin Transplant 2006; 20: 582.
20. Chang SH, Coates PT, McDonald SP. Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation 2007; 84: 981.
21. Molnar MZ, Kovesdy CP, Mucsi I, et al. Higher recipient body mass index is associated with post-transplant delayed kidney graft function. Kidney Int 2011; 80: 218.
22. Gore JL, Pham PT, Danovitch GM, et al. Obesity and outcome following renal transplantation. Am J Transplant 2006; 6: 357.
23. Papalia T, Greco R, Lofaro D, et al. Impact of body mass index on graft loss in normal and overweight patients: retrospective analysis of 206 renal transplants. Clin Transplant 2010; 24: E241.
24. Akhlaghi F, Trull AK. Distribution of cyclosporin in organ transplant recipients. Clin Pharmacokinet 2002; 41: 615.
25. Shibata N, Hoshino N, Minouchi T, et al. Relationship between area under the concentration versus time curve of cyclosporin A, creati-nine clearance, hematocrit value, and other clinical factors in Japanese renal transplant patients. Int J Clin Pharmacol Ther 1998; 36: 202.
26. Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134.
27. Okamoto Y, Christen T, Shimizu K, et al. Adiponectin inhibits allo-graft rejection in murine cardiac transplantation. Transplantation 2009; 88: 879.
28. Patel S, Pankewycz O, Kohli R, et al. Obesity in renal transplantation: the role of induction therapy on long-term outcomes. Transplant Proc 2011; 43: 469.
29. Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000; 278: F817.
30. Tsuboi N, Utsunomiya Y, Kanzaki G, et al. Low glomerular density with glomerulomegaly in obesity-related glomerulopathy. Clin J Am Soc Nephrol 2012; 7: 735.
31. Teplan V, Schuck O, Racek J, et al. Asymmetric dimethylarginine and adiponectin after renal transplantation: role of obesity. J Ren Nutr 2008; 18: 154.
32. Kielstein JT, Boger RH, Bode-Boger SM, et al. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 2002; 13: 170.
33. Shu KH, Tsai IC, Ho HC, et al. Serum adiponectin levels in renal transplant recipients with and without metabolic syndrome. Transplant Proc 2012; 44: 676.
34. Roos M, Baumann M, Liu D, et al. Low pre-transplant adiponectin multimers are associated with adverse allograft outcomes in kidney transplant recipients: a 3-year prospective study. Regul Pept 2012; 178: 11.
35. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464.
36. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009; 338: b2393.